• image_1
  • image_2
  • css image gallery
  • image_4
slider html by WOWSlider.com v9.0
> Tuberculosis
> Primary Health Care
> Nutrition
> Aid and Relief
> Leprosy
 

Tuberculosis

Approximately 1.4 million people died from TB-related illnesses in 2019. Of the estimated 10 million people who developed TB that year, some 3 million were not diagnosed with the disease, or were not officially reported to national authorities.
The situation is even more acute for people with drug-resistant TB. About 465 000 people were newly diagnosed with drug-resistant TB in 2019 and, of these, less than 40% were able to access treatment. There has also been limited progress in scaling up access to treatment to prevent TB.
“Equitable access to quality and timely diagnosis, prevention, treatment and care remains a challenge,”
“Accelerated action is urgently needed worldwide if we are to meet our targets by 2022.”
About 14 million people were treated for TB in the period 2018-2019, just over one-third of the way towards the 5-year target (2018-2022) of 40 million, according to the report. Some 6.3 million people started TB preventive treatment in 2018-2019, about one-fifth of the way towards the 5-year target of 30 million.
Funding is a major issue. In 2020, funding for TB prevention, diagnosis, treatment and care reached US$ 6.5 billion, representing only half of the US$ 13 billion target agreed by world leaders in the UN Political Declaration on TB.

The COVID-19 pandemic and TB
Disruptions in services caused by the COVID-19 pandemic have led to further setbacks.  In many countries, human, financial and other resources have been reallocated from TB to the COVID-19 response. Data collection and reporting systems have also been negatively impacted.

Achievements 2020

  • 4850 all TB cases detected
  • 4772TB bacteriological confirmed plus clinical diagnosed, new and relapse
  • 123,110 people benefitted from health education
  • 4,646 TB patients tested for HIV